Heavy periods. Pelvic pressure. Bloating. Abnormal bleeding. When these symptoms appear, many women and sometimes even their providers attribute them to uterine fibroids, one of the most common benign gynecologic conditions. And often, that’s exactly right. But uterine cancer can produce overlapping symptoms, and distinguishing between the two requires more than a symptom checklist. At Ovation OB/GYN in Frisco, Texas, we want every woman to understand what sets these conditions apart;  because clarity is the foundation of appropriate care.

“Everyone was very kind and Dr van Deventer took time to explain the sonogram results and why we needed to biopsy.”

-Ovation OB/GYN Patient Testimonial 

What Are Uterine Fibroids?

Uterine fibroids, also called leiomyomas or myomas, are noncancerous growths of the muscular wall of the uterus. They are extraordinarily common: estimates suggest that up to 80 percent of women will develop fibroids by age 50, though many will never know it because their fibroids cause no symptoms. When fibroids do cause symptoms, the most common include heavy or prolonged menstrual bleeding, pelvic pain or pressure, urinary frequency, and in some cases, difficulty conceiving or carrying a pregnancy to term. Fibroids vary enormously in size: from microscopic to as large as a grapefruit and in location within or around the uterus, both of which influence whether and what symptoms they cause. Our fibroids services include comprehensive evaluation and a range of treatment options tailored to each patient’s symptoms, size, location, and fertility goals.

Fibroids are estrogen-sensitive, meaning they tend to grow during the reproductive years when estrogen levels are high and typically shrink after menopause when estrogen declines. This hormonal dependence is one of the reasons that fibroid symptoms often peak in the late 30s and 40s, before menopause brings relief.

What Is Uterine Cancer?

Uterine cancer, most commonly endometrial cancer, which begins in the lining of the uterus is the most common gynecologic cancer in the United States. It differs from fibroids in a fundamental way: it is malignant, meaning it has the potential to invade surrounding tissue and spread to other parts of the body if not treated.

Endometrial cancer is most often diagnosed in postmenopausal women, with the average age at diagnosis around 60. Its most common and clinically important warning sign is abnormal uterine bleeding; particularly any vaginal bleeding after menopause, which should always be evaluated and never assumed to be normal. In premenopausal women, significantly irregular or heavy bleeding may also prompt evaluation.

Risk factors for endometrial cancer include obesity (which elevates circulating estrogen levels), estrogen dominance, diabetes, a history of PMOS (formerly PCOS: Polyendocrine Metabolic Ovarian Syndrome), never having been pregnant, late menopause, certain medications such as tamoxifen, and a family history of Lynch syndrome or uterine cancer.

The Symptom Overlap and What Distinguishes Them

The symptom overlap between fibroids and endometrial cancer is real and creates genuine diagnostic complexity. Both conditions can cause heavy or abnormal uterine bleeding, pelvic discomfort, and bloating. So how do providers distinguish between them?

Age and menopausal status are among the most important clinical factors. Fibroids are common throughout the reproductive years and typically regress after menopause. Endometrial cancer is primarily a postmenopausal condition. Any uterine bleeding that occurs after menopause, regardless of how light or intermittent, warrants prompt evaluation for endometrial cancer.

Type and pattern of bleeding: Fibroid-related bleeding is typically heavy menstrual bleeding: excessively heavy or prolonged periods. Endometrial cancer often produces irregular, unpatterned bleeding that doesn’t follow a menstrual schedule, or postmenopausal bleeding.

Imaging findings: A pelvic ultrasound can identify fibroids clearly; they appear as distinct, well-defined masses within the uterine wall or cavity. Endometrial cancer cannot be diagnosed by ultrasound alone, but ultrasound can identify a thickened endometrial lining that prompts further evaluation.

Endometrial biopsy: The definitive test for endometrial cancer is an endometrial biopsy: a procedure that samples cells from the uterine lining. This can be performed in-office and is recommended when abnormal bleeding is unexplained by imaging or when endometrial cancer is a concern. A hysteroscopy may also be used to directly visualize the uterine cavity.

Treatment: Very Different Paths

When fibroids are the diagnosis, treatment depends on symptom severity, fibroid size and location, and a woman’s fertility goals. Many women with asymptomatic fibroids require no treatment at all. For those with significant symptoms, options range from hormonal management to NovaSure endometrial ablation, minimally invasive surgical procedures such as laparoscopic myomectomy, and in some cases hysterectomy.

Endometrial cancer treatment is quite different. The cornerstone of treatment is surgery; typically a hysterectomy with removal of the fallopian tubes and ovaries,  often followed by radiation therapy, chemotherapy, or targeted agents depending on the stage and tumor characteristics. Because endometrial cancer is so frequently caught at an early stage due to its characteristic bleeding symptom, the majority of women are diagnosed with Stage I disease, which carries an excellent prognosis.

“Dr. Van Deventer has excellent bedside manners! Appointment was not rushed and she took the time to answer all my questions with care. She was also open to what my gynecological goals were in regard to future family planning. “

-Ovation OB/GYN Patient Testimonial 

When to Seek Evaluation

The most important takeaway from this comparison is not to self-diagnose. If you are experiencing heavy or irregular bleeding, pelvic pressure, or any postmenopausal bleeding, the appropriate next step is evaluation; not assumption. Fibroids are far more common than endometrial cancer, but that statistical likelihood is not a reason to skip the workup that would distinguish between them.

At Ovation OB/GYN, we provide comprehensive evaluation and management for both fibroids and gynecologic cancers, with the full range of diagnostic and treatment options available in our Frisco, Texas practice. If you have symptoms that need evaluation, don’t wait. Request an appointment online or call us at (972) 777-3232.